📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression. (2017)

First Author: Roseman L

Attributed to: Psilocybin as a treatment for major depression funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2017.00974

PubMed Identifier: 29387009

Publication URI: http://europepmc.org/abstract/MED/29387009

Type: Journal Article/Review

Volume: 8

Parent Publication: Frontiers in pharmacology

ISSN: 1663-9812